Veristat will attend the upcoming ASH Annual Meeting 2018 taking place in San Diego, California from Dec 1-4, 2018, the premier event in malignant and non-malignant hematology.
August 29, 2018
Meet Veristat at booth # 24 at OCT SoCal 2018! As a full service CRO providing impactful strategies and solutions, Veristat can meet all of your outsourcing needs to support your next clinical trial, program or regulatory submission project.
August 28, 2018
Join Veristat Data Managers at the No. 1 Clinical Data Management Event, SCDM 2018! The event takes place this year on September 23-26 in Seattle, WA.
July 23, 2018
Join us at the world’s largest statistical conference, the Joint Statistical Meeting 2018 taking place in Vancouver from July 28- August 2, 2018, to see Veristat’s Mark Chang Speak on the "Controversies of Rare Disease Clinical Trial Design and Personalized Medicine" on August 1, 2018.
Veristat is proud to be participating at a Rare Disease Workshop on July 18, 2018 taking place at Biogen. Veristat's statitiscal and adaptive design expert, Mark Chang, PhD will be will be speaking about the “Controversies in Rare Disease Trial Designs and Personalized Medicine”.
Meet with Veristat to explore the successful strategies we employ to improve the success of oncology clinical trials and regulatory submission programs.
Veristat is attending the Outsourcing in Clinical Trials UK & Ireland Event taking place on June 12-13, 2018 in London. This event will focus on strategies to streamline and innovate clinical trial operations in the UK & Ireland region despite the shifting political and regulatory changes affecting the region.
Different Approaches for Preparing a Marketing Application: A Review of Successful NDA/MAA Preparation Strategies
Veristat is looking forward to attending and exhibiting at the largest global industry event where the newest discoveries in cancer research are revealed, the 2018 ASCO Annual Meeting. This year’s meeting focuses on the theme of “Delivering Discoveries, Enabling the Reach of Precision Medicine”, which is the new trend driving oncology clinical research today.